Analysis of antigen-specific B-cell subsets, amongst total B cells, show that the frequencies of RBD+ and S1+ MBCs in SLE patients were decreased (a trend for RBD and significant for S1) compared to healthy controls even after 3+ doses of vaccine (Fig. 3D and E). Here, PSMD1 is linked to systemic lupus erythematosus.